BACKGROUND: Long-acting injectable depot buprenorphine is an important new treatment option for the management of opioid dependence, delivering therapeutic doses in weekly or monthly formulations. Depot buprenorphine aims to overcome challenges associated with traditional opioid agonist therapy (OAT), including: poor patient adherence; inconvenience of regular attendance for dosing; and, risk of non-medical use of takeaway doses. However, little is known about patients' experiences of depot buprenorphine. This qualitative study aimed to explore patients' experiences of the practical and social affordances of depot buprenorphine. METHODS: Participants were recruited from sites in Sydney, regional New South Wales, and Melbourne, Victoria, ...
Abstract Background Options for opioid agonist therapy (OAT) are expanding with the development of p...
BACKGROUND: Out-of-pocket costs for opioid agonist treatment (OAT) constitute a barrier to treatment...
Background: Opioid agonist treatment (OAT) is an effective intervention for opioid dependence. Exten...
Aims: To examine perceptions of extended-release (XR) buprenorphine injections among people who regu...
BACKGROUND: Recently developed buprenorphine depot injections have the potential to reduce risk for ...
Background: Recently developed buprenorphine depot injections have the potential to reduce risk for ...
BACKGROUND AND AIMS: To examine characteristics of first-time methadone and buprenorphine clients an...
INTRODUCTION: People experiencing homelessness often experience intersecting mental and physical hea...
Introduction: People experiencing homelessness often experience intersecting mental and physical hea...
BACKGROUND AND AIMS: Opioid agonist treatment is effective but resource intensive to administer safe...
BACKGROUND: Opioid agonist treatment (OAT) is an effective intervention for opioid dependence. Exten...
Background and aims: Not all people experiencing opioid dependence benefit from oral opioid agonist ...
Background and Aims: Not all people experiencing opioid dependence benefit from oral opioid agonist ...
The use of heroin in Australia results in disproportionate harm. Although the evidence suggests that...
Aim: To discuss the use of 6‐monthly buprenorphine implants for maintenance treatment of opioid use ...
Abstract Background Options for opioid agonist therapy (OAT) are expanding with the development of p...
BACKGROUND: Out-of-pocket costs for opioid agonist treatment (OAT) constitute a barrier to treatment...
Background: Opioid agonist treatment (OAT) is an effective intervention for opioid dependence. Exten...
Aims: To examine perceptions of extended-release (XR) buprenorphine injections among people who regu...
BACKGROUND: Recently developed buprenorphine depot injections have the potential to reduce risk for ...
Background: Recently developed buprenorphine depot injections have the potential to reduce risk for ...
BACKGROUND AND AIMS: To examine characteristics of first-time methadone and buprenorphine clients an...
INTRODUCTION: People experiencing homelessness often experience intersecting mental and physical hea...
Introduction: People experiencing homelessness often experience intersecting mental and physical hea...
BACKGROUND AND AIMS: Opioid agonist treatment is effective but resource intensive to administer safe...
BACKGROUND: Opioid agonist treatment (OAT) is an effective intervention for opioid dependence. Exten...
Background and aims: Not all people experiencing opioid dependence benefit from oral opioid agonist ...
Background and Aims: Not all people experiencing opioid dependence benefit from oral opioid agonist ...
The use of heroin in Australia results in disproportionate harm. Although the evidence suggests that...
Aim: To discuss the use of 6‐monthly buprenorphine implants for maintenance treatment of opioid use ...
Abstract Background Options for opioid agonist therapy (OAT) are expanding with the development of p...
BACKGROUND: Out-of-pocket costs for opioid agonist treatment (OAT) constitute a barrier to treatment...
Background: Opioid agonist treatment (OAT) is an effective intervention for opioid dependence. Exten...